US FDA Taps Merck Drugs With Blockbuster Sales Potential for National Priority Vouchers
Wedoany.com Report-Dec.18, The U.S. Food and Drug Administration plans to accelerate reviews for two...
Novartis, Roche Near US Drug Price Deal
Wedoany.com Report-Dec.18, The White House is preparing to disclose agreements on medication pricing...
J&J Gains Label Expansion Approval for Akeega in MCSPC
Wedoany.com Report-Dec.17, Johnson & Johnson has obtained U.S. regulatory approval to extend the...
SK Capital Partners Supports Swixx BioPharma’s Global Expansion
Wedoany.com Report-Dec.17, An affiliate of U.S.-based private investment firm SK Capital Partners ha...
Pfizer Trims 2026 Profit Forecast Amid COVID Headwinds and Patent Cliff Pressures
Wedoany.com Report-Dec.17, Pfizer has issued a fiscal year 2026 earnings projection below consensus ...
GSK Wins US Approval for Twice-Yearly Asthma Drug
Wedoany.com Report-Dec.17, The U.S. Food and Drug Administration has authorized GSK's medication Ex...
UK Approves GSK’s Twice-Yearly Asthma Drug
Wedoany.com Report-Dec.16, The UK's Medicines and Healthcare products Regulatory Agency announced o...
AstraZneca, Daiichi’s Breast Cancer Drug Gets FDA Nod as First-Line Treatment
Wedoany.com Report-Dec.16, The U.S. Food and Drug Administration announced on Monday the approval of...
FDA Has No Plans to Put Most Serious Warning on COVID Vaccines
Wedoany.com Report-Dec.16, The U.S. Food and Drug Administration has no current intention to add a b...
South Korea’s ADEL Signs up to $1.04 Billion Alzheimer’s Drug Development Deal With Sanofi
Wedoany.com Report-Dec.16, South Korean biotechnology company ADEL announced late Monday a partnersh...